Transaction details
The proposed acquisition by Jaguar Holding Company I of sole control of Synexus Clinical Research Topco Limited has been cleared by the Competition and Consumer Protection Commission.
| Economic sector | Media merger |
| Pharmaeuticals | No |
Notification date: Wednesday, April 13, 2016
| Parties Involved | Business activities |
| Jaguar Holding Company I. | Jaguar Holding Company I,is a USA-based Holding Company. |
| Synexus Clinical Research Topco Limited | The target, Synexus Clinical Research Topco Limited, is involved in managing pharmaceutical clinical trials. |
| Case Officer Assigned | Contact Details |
| Andrew Rae | Tel: 470-3671
Email: [email protected] |
|
Media Enquiries |
MKC Communications: 01 7038600 |
The deadline for any third parties who wish to make submissions regarding the competition aspects of this merger is:
| Phase 1 |
| Wednesday, April 27, 2016 |
|
Current status |
Completed |
Cleared (Phase 1) |
Decision date: Thursday, May 12, 2016
